Taltirelin 5mg (Sawai) 28tab.
Forma farmacéutica
- Tablets: white, 7.0 mm in diameter, 2.9 mm thick.
- Package: 28 tablets.
Tenga en cuenta que el aspecto del envase puede variar según el fabricante y la región de venta.
Principio activo
Taltireline hydrate is 5 mg in each tablet.
Dosificación
- Adults: 1 tablet (5 mg) 2 times a day — in the morning and in the evening after meals.
- Dose adjustment: possible depending on the age and symptoms of the patient; strictly follow the doctor's instructions.
Taltirelin is a synthetic analogue of thyrotropin-releasing hormone (TRH) used to alleviate symptoms of ataxia in patients with spinocerebellar degeneration.
Indications for Use:
- Spinocerebellar Degeneration:
- Symptomatic improvement of ataxia, including:
- Impaired coordination of movements.
- Gait instability.
- Changes in speech.
- Abnormal eye movements (nystagmus or other ocular motility disorders).
- Symptomatic improvement of ataxia, including:
Contraindications:
- Hypersensitivity to taltirelin or any components of the drug.
- Pregnancy and Breastfeeding: Use is not recommended due to insufficient safety data.
- Pediatric Use: Safety and efficacy have not been established in children.
Side Effects:
- Nervous System:
- Headache, dizziness, drowsiness.
- Digestive System:
- Nausea, vomiting, reduced appetite.
- Allergic Reactions:
- Skin rash, pruritus (itching).
- Other:
- Fatigue, fever.
Special Instructions:
- Patients with Liver or Kidney Impairment:
- Caution is advised, with potential need for dose adjustments.
- Drug Interactions:
- Inform your healthcare provider about all medications being taken to avoid adverse interactions.
- Driving and Machinery Operation:
- Exercise caution when driving or operating machinery due to potential side effects such as dizziness or drowsiness.
- Consultation Recommended:
- Before starting Taltirelin, consult a healthcare provider to assess the appropriateness of therapy and determine the optimal dosage. Self-medication may result in undesirable consequences.
